Zobrazeno 1 - 10
of 119
pro vyhledávání: '"J.A. Upcroft"'
Publikováno v:
ELECTROPHORESIS. 32:2075-2090
We barcoded 25 in vitro isolates (representing 92 samples) of Giardia duodenalis from humans and other animals, which have been assembled by the Upcroft team at the Queensland Institute of Medical Research over a period of almost three decades. We us
Autor:
Steven A. Sullivan, Melissa D. Conrad, Jane M. Carlton, J.A. Upcroft, Jan Tachezy, Zuzana Zubáčová, Linda A. Dunn
Publikováno v:
Molecular and Biochemical Parasitology. 175:30-38
Given the growing appreciation of serious health sequelae from widespread Trichomonas vaginalis infection, new tools are needed to study the parasite's genetic diversity. To this end we have identified and characterized a panel of 21 microsatellites
Autor:
Peter Upcroft, J.A. Upcroft
Publikováno v:
BioEssays. 20:256-263
The gut protozoan parasite, Giardia duodenalis, is the best characterized example of the most ancient eukaryotes, which are anaerobic and appear to be primitively amitochondrial. Apart from its obvious medical importance, Giardia is fascinating in it
Publikováno v:
International Journal for Parasitology. 28:149-164
The protozoan parasite, Giardia duodenalis, shares many metabolic and genetic attributes of the bacteria, including fermentative energy metabolism which relies heavily on pyrophosphate rather than adenosine triphosphate and as a result contains two t
Publikováno v:
Acta Tropica. 60:221-224
Autor:
Maxime D. Crozet, Thierry Terme, Patrice Vanelle, Kevin S. W. Tan, Thierry Juspin, Peter Upcroft, Linda A. Dunn, J.A. Upcroft
Publikováno v:
Parasitology Research
Parasitology Research, Springer Verlag (Germany), 2012, 111 (1), pp.441--450. ⟨10.1007/s00436-012-2860-7⟩
Parasitology Research, 2012, 111 (1), pp.441--450. ⟨10.1007/s00436-012-2860-7⟩
Parasitology Research, Springer Verlag (Germany), 2012, 111 (1), pp.441--450. ⟨10.1007/s00436-012-2860-7⟩
Parasitology Research, 2012, 111 (1), pp.441--450. ⟨10.1007/s00436-012-2860-7⟩
International audience; Metronidazole (MTR) is frequently used for the treatment of Blastocystis infections, but with variable effectiveness, and often with treatment failures as a possible result of drug resistance. We have developed two Blastocysti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40eab1309cf4ec1d8083e8442e11a21f
https://hal-amu.archives-ouvertes.fr/hal-01460365
https://hal-amu.archives-ouvertes.fr/hal-01460365
Autor:
J.A. Upcroft, Peter Upcroft
Publikováno v:
Parasitology Today. 9:187-190
Giardiasis is a worldwide disease that can cause serious morbidity. Metronidozole is the current recommended drug for treatment, and is mostly still effective. However, Giardia duodenalis , the causative agent, is capable of developing resistance to
Publikováno v:
Antimicrobial agents and chemotherapy. 55(2)
Blastocystis is an emerging protistan parasite of controversial pathogenesis. Although metronidazole (Mz) is standard therapy for Blastocystis infections, there have been accumulating reports of treatment failure, suggesting the existence of drug-res
Publikováno v:
The Journal of parasitology. 96(3)
The gut protozoan parasite, Giardia lamblia (Assemblage A), has 5 major chromosomes, 1 of which is 2 Mb, as determined from gel separations of whole chromosomes. We originally published a physical map of this chromosome and, now, using the sequence d
Publikováno v:
Trends in parasitology. 26(10)
Two genotypes, assemblages A and B, of the pathogenic gut protozoan parasite Giardia lamblia infect humans. Symptoms of infection range from asymptomatic to chronic diarrhea. Giardia chromosomes have long been characterized but not until the publicat